City University of New York (CUNY)

CUNY Academic Works
Publications and Research

Queens College

2009

Xmc Mediates Xctr1-Independent Morphogenesis in Xenopus
laevis†
laevis
Tomomi Haremaki
CUNY Queens College

Daniel C. Weinstein
CUNY Queens College

How does access to this work benefit you? Let us know!
More information about this work at: https://academicworks.cuny.edu/qc_pubs/91
Discover additional works at: https://academicworks.cuny.edu
This work is made publicly available by the City University of New York (CUNY).
Contact: AcademicWorks@cuny.edu

DEVELOPMENTAL DYNAMICS 238:2382–2387, 2009

SPECIAL ISSUE RESEARCH ARTICLE

Xmc Mediates Xctr1-Independent
Morphogenesis in Xenopus laevis†
Tomomi Haremaki and Daniel C. Weinstein*

In the frog, Xenopus laevis, ﬁbroblast growth factor (FGF) signaling is required for both mesoderm
formation and the morphogenetic movements that drive the elongation of the notochord, a dorsal
mesodermal derivative; the coordination of these distinct roles is mediated by the Xenopus Ctr1 (Xctr1)
protein: maternal Xctr1 is required for mesodermal differentiation, while the subsequent loss of Xctr1
promotes morphogenesis. The signaling cascade activated by FGF in the presence of Ctr1 has been well
characterized; however, the Xctr1-independent, FGF-responsive network remains poorly deﬁned. We have
identiﬁed Xenopus Marginal Coil (Xmc) as a gene whose expression is highly enriched following Xctr1
knockdown. Zygotic initiation of Xmc expression in vivo coincides with a decrease in maternal Xctr1
transcripts; moreover, Xmc loss-of-function inhibits Xctr1 knockdown-mediated elongation of FGF-treated
animal cap explants, implicating Xmc as a key effector of Xctr1-independent gastrular morphogenesis.
Developmental Dynamics 238:2382–2387, 2009. © 2009 Wiley-Liss, Inc.
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INTRODUCTION
Vertebrate development is driven largely
by inductive interactions, during which
one group of cells inﬂuences the fate of
another, often by means of the activity of
secreted extracellular ligands. A striking
feature of embryonic induction is the
prominence of a small set of ligands in
these varied interactions, from germ
layer formation and early patterning to
morphogenesis and organogenesis. This
observation raises an important question
regarding signal interpretation; that is,
how does the embryo ensure that a given
signal elicits a response that is speciﬁc,
and biologically appropriate, to the responding cell? At least two distinct scenarios are plausible. On the one hand,
one could envision that a single “core”

pathway induced by a given ligand
could be modiﬁed, at or near the cascade’s terminus, by a set of transcriptional effectors speciﬁc to one or a few
cell types. Alternatively, a single ligand-receptor pair could induce largely
distinct signaling cascades, depending
upon the cellular context in which the
induction takes place.
Members of the ﬁbroblast growth
factor (FGF) family play a critical role
during innumerable steps of embryogenesis. In the frog, Xenopus laevis,
FGF is essential for maintaining the
differentiation of the mesodermal
germ layer, ﬁrst induced by transforming growth factor-␤ (TGF␤) signaling (Heasman, 2006). Shortly after
the initiation of gastrulation, FGF re-

†

ceptor activation no longer supports
mesodermal differentiation; instead,
FGF signaling promotes the dramatic
lengthening of both the notochord, a
dorsal mesodermal derivative, and the
caudal neural tube, by means of the
morphogenetic processes of convergence and extension (Nutt et al.,
2001). FGF mediated-mesoderm induction results from activation of the
“canonical” Ras/MAPK cascade (Heasman, 2006); FGF-mediated morphogenesis, however, results instead from
the activation of Ras/MAPK-independent “noncanonical” FGF signaling
(Nutt et al., 2001). These distinct
FGF-dependent pathways are distinguished not only by their activating
components, but by their distinct re-
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pressors, as well: the Xenopus Spred
proteins block Ras/MAPK signaling;
while the related Sprouty proteins inhibit Ca2⫹ and PKC␦ “noncanonical”
signaling (Sivak et al., 2005). Thus,
the shift in the biological consequence
of FGF signaling is due to a shift in
the signaling cascades stimulated by
FGF receptor activation.
A key mechanism by which early
embryonic cells “translate” FGF receptor activity into a speciﬁc signaling
cascade and subsequent biological activity hinges on the presence or absence of the Ctr1 protein within the
plasma membrane-associated FGF
signaling complex. The maternal Xenopus Ctr1 (Xctr1) protein facilitates
phosphorylation of the FGF receptorassociated docking protein SNT-1/
FRS2␣ by the FGF receptor and the
Laloo nonreceptor tyrosine kinases, as
well as the phosphorylation and activation of ERK, the latter event a deﬁning step in “canonical” FGF signaling (Hama et al., 2001; Heasman,
2006; Haremaki et al., 2007). Consistent with this biochemical activity,
Xctr1 misexpression enhances FGFmediated mesoderm induction, and
inhibits convergent extension, both in
explants and in vivo (Haremaki et al.,
2007). Conversely, loss of Xctr1 inhibits mesoderm differentiation and instead promotes mesodermal and neural morphogenesis (Haremaki et al.,
2007).
While it is clear that loss of Xctr1
both inhibits differentiation and promotes gastrular morphogenesis, little
is yet known of the “noncanonical” signaling cascade that is activated by
FGF in the absence of Xctr1. In an
attempt to address the mechanisms
by which Xctr1 elimination promotes
coordinated tissue movements, we
performed gene array studies to identify transcripts that were robustly enriched by FGF in the absence of Xctr1.
We have identiﬁed several genes that
are highly expressed following Xctr1
knockdown. One of these, Xenopus
Marginal Coil (Xmc), a gene previously described as an FGF-responsive
transcript, was selected for further
study (Frazzetto et al., 2002). Xmc expression initiates shortly after the initial clearing of maternal Xctr1 transcripts in the Xenopus embryo, and
Xmc loss-of-function inhibits Xctr1
knockdown-mediated elongation by

FGF, indicating that Xmc is necessary
for FGF-stimulated, Xctr1-independent morphogenesis.

RESULTS
We have previously demonstrated
that Xctr1 loss-of-function promotes
FGF-mediated elongation of Xenopus
explant cultures (Haremaki et al.,
2007). While several signaling components have been implicated in caudal
neural and dorsal mesodermal morphogenesis, little is known about the
regulation of these events at the level
of gene expression. To characterize
the transcriptional response to Xctr1
knockdown, we performed microarray
analyses to compare the expression
proﬁles of FGF-treated animal caps
from embryos injected with either
Xctr1-speciﬁc (Xctr1MO) or 5-base
pair mismatch- (Xctr1MM) morpholinos; Xctr1MM does not inhibit Xctr1
translation, in vitro (Haremaki et al.,
2007). A representative experiment is
shown in Figure 1; the lack of effect on
“housekeeping” genes (e.g., EF1-a)
and the reduction of dorsal mesodermspeciﬁc genes (e.g., muscle actin) following Xctr1 knockdown point to the
quality of these data sets (Fig. 1; Mohun et al., 1984; Krieg et al., 1989).
Our aim in these studies was to identify genes whose expression was
strongly induced following Xctr1 knockdown. We reasoned that, because both
neural and mesodermal differentiation
were inhibited by Ctr1 elimination, the
genes we identiﬁed as “up-regulated” in
our analysis were not likely to represent
molecular markers of induced cell fates
and were, thus, reasonable candidate
effectors of Ctr1 knockdown-mediated
morphogenesis. We identiﬁed 25 annotated genes with greater than threefold
elevated expression, following Xctr1
knockdown in FGF-treated neurula
stage animal cap explants, in each of
two independent microarray experiments (Table 1). Candidates selected for
independent veriﬁcation were conﬁrmed by reverse transcriptase-polymerase chain reaction (RT-PCR; Table
1, bold, Fig. 2, and data not shown).
Strikingly, exogenous FGF was not required for enhanced expression of these
transcripts; knockdown of Xctr1 was
alone sufﬁcient to stimulate this response (Fig. 2).
To narrow the pool of candidate effec-

tors, we reasoned that mediators of
Xctr1-independent morphogenesis might
also show a reduction in transcript
abundance following Xctr1 misexpression, as Xctr1 inhibits elongation of
both dorsal mesoderm and caudal
neurectoderm (Haremaki et al., 2007).
We therefore performed an additional
microarray study to select for transcripts down-regulated by Xctr1 in animal cap explants. Figure 3A shows
the effects of Xctr1 misexpression on
transcripts shown to be up-regulated
in the Xctr1 knockdown microarray
studies. Of the transcripts enriched
following injection of Xctr1 morpholino oligos (Fig. 3A, left panel, red),
only two were signiﬁcantly down-regulated following misexpression of
Xctr1 RNA (Fig. 3A, right panel, arrows pointing to bright green bands).
Both of these bands correspond to Xenopus marginal coil (Xmc). The FGFinducible Xmc gene encodes a coiledcoil protein previously implicated in
the regulation of gastrulation movements (Frazzetto et al., 2002); it was
thus chosen for further analysis. RTPCR was used to conﬁrm that Xctr1
knockdown enhances Xmc expression
in the presence of FGF (Fig. 3B). Xmc
transcripts are also enriched following
Xctr1 knockdown in the absence of
FGF (Fig. 3C). We next conﬁrmed, using RT-PCR, that Xctr1 misexpression
down-regulates Xmc in animal caps
(Fig. 3D,E, lanes 1 and 2). FGF protein induces robust expression of Xmc
in animal cap explants, presumably
reﬂecting mesodermal Xmc expression; Activin protein induces levels
similar to those seen with FGF (Fig.
3E, compare lanes 2, 3, and 5;
Frazzetto et al., 2002). Ectopic Xctr1
does not, however, inhibit Xmc expression in either FGF- or Activin-treated
caps (Fig. 3E). These data demonstrate that Xctr1 loss-of-function enhances Xmc expression in both ectoderm and mesoderm, and that Xctr1
gain-of-function suppresses Xmc expression in ectoderm, but not mesoderm.
Our studies suggest that Xctr1
knockdown may promote morphogenesis by means of induction of Xmc.
Consistently, we ﬁnd that initiation of
Xmc expression coincides with the decline in maternal Xctr1 expression
(Fig. 4; Frazzetto et al., 2002; Haremaki et al., 2007). Coupled with the
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Fig. 1. Microarray analysis of Xctr1 knockdown. Data shown are from a representative Affymatrix
gene chip hybridization; signal strength was visualized using Affymetrix GeneChip Operating
Software 1.4. Transcripts that register hybridization signal with both probes (“Xctr1MO and
”Xctr1MM“) are shown in red. Transcripts that register ”absent“ or ”marginal“ hybridization signal
with one probe are shown in blue; transcripts that register ”absent“ or ”marginal“ hybridization
signal with both probes are shown in yellow. Examples of unaffected (EF1-␣) and down-regulated
(Muscle actin) transcripts are highlighted (arrows); number ⫽ fold change.

Fig. 3. Regulation of Xmc by Xctr1. A: Xmc expression is suppressed by Xctr1. Microarray
analysis of gene expression in embryos injected with RNA encoding either Xctr1 or ␤-galactosidase.
Left column: genes that are expressed more highly in ﬁbroblast growth factor (FGF) treated caps
taken from Xctr1MO injected embryos than in FGF treated caps taken from Xctr1MM injected
embryos. Right column: Relative expression of genes from left column in animal caps from embryos
injected with either Xctr1 or ␤-gal RNA. Up-regulated genes are shown in red; down-regulated
genes are shown in green. Arrows point to two transcripts that are strongly down-regulated by
Xctr1 (top: 38%, bottom: 28% of signal in ␤-galactosidase-injected control samples); both transcripts encode Xmc. B–E: Reverse transcriptase-polymerase chain reaction (RT-PCR) conﬁrmation
of microarray data presented in A. B: Xmc expression is elevated following Xctr1 knockdown in
FGF-treated animal caps. C: Xmc expression is elevated following Xctr1 knockdown in animal caps
cultured in saline. D: Xmc expression is suppressed following Xctr1 misexpression in animal caps.
E: Xctr1 does not inhibit Xmc induction by either FGF or Activin protein. Ectopic Xctr1 inhibited
Activin-mediated cap elongation in these assays (data not shown). A total of 10 ng/ml bFGF, 0.5
ng/ml Activin was added, as shown. A total of 250 ng of Xctr1 morpholino (Xctr1MO) and 250 ng
of Xctr1 mismatch morpholino (Xctr1MM) were injected, as shown. Also, 1 ng of Xctr1 and 1 ng of
␤-galactosidase RNA was injected, as shown.

Fig. 2. Conﬁrmation of genes with elevated
transcription following Xctr1 knockdown. Reverse transcriptase-polymerase chain reaction
(RT-PCR) analysis of gene expression in stage
22 animal cap explants. Injection protocol
and/or culture conditions are shown at top. A
total of 10 ng/ml basic ﬁbroblast growth factor
(bFGF) was added, as shown. A total of 250 ng
of Xctr1 morpholino (Xctr1MO) and 250 ng of
Xctr1 mismatch morpholino (Xctr1MM) were injected, as shown. The induction by HoxB9, a
marker of lateral plate mesoderm and spinal
cord at this stage, demonstrates that FGF is
active in this experiment (Wright et al., 1990).
The “⫺RT” lane contains all reagents except
reverse transcriptase and was used as a negative control. Ornithine decarboxylase (ODC) is
used as a loading control (Bassez et al., 1990).

gain- and loss-of-function analyses described above, these correlative data
provide further evidence for regulation of Xmc by Xctr1, in vivo.
We observed no effects on cell fate
determination or morphogenesis from
Xmc misexpression in ectodermal or
mesodermal explants, including animal caps treated with FGF and/or Activin, or in intact Xenopus embryos,
consistent with earlier published
studies (data not shown; Frazzetto et
al., 2002), suggesting that Xmc gainof-function is not sufﬁcient to alter
morphogenesis. We next sought to address the potential requirement for
Xmc in mediating Xctr1-independent
morphogenesis. Knockdown of Xmc
function by means of Xmc-speciﬁc antisense morpholino oligonucleotides
has been shown to affect axial elongation in Xenopus (Frazzetto et al.,
2002); morpholino studies were thus
used to further address the relationship between Xmc and Xctr1 during
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TABLE 1. Candidate Mediators of Ctrl-Independent Morphogenesis
ID

Symbol

Name

Fold change

XI.5274.1.S1_at
XI.585.1.S1_at
XI.1262.1.S1_at
XI.1268.1.S1_at
XI.973.1.S1_at
XI.5454.1.S2_at
XI.446.1.S1_at
XI.5888.2.S1_at
XI.869.1.S2_at
XI.11672.1.A1_at
XI.798.1.S1_at
XI.7590.2.A1_at
XI.5288.1.S1_at
XI.25540.3.A1_at
XI.699.1.S1_s_at
XI.2582.1.S1_at

DasraA
ESR-6e
LOC397921
Otx2
LOC397824
Xmc
xlZPA
rGAP
LOC397936
Otx2
B4
LOC397951
LOC398163
LOC398660
LOC397948
rgma

7.80
6.74
5.83
4.80
4.34
4.15
3.88
3.67
3.65
3.65
3.56
3.44
3.42
3.41
3.41
3.31

XI.8340.2.A1_a_at
XI.15540.2.A1_at
XI.8719.1.S1_at
XI.17481.1.A1_at

ppm1d
atf5
dynII2
mthfd2

XI.15540.1.A1_at
XI.1592.1.A1_at
XI.8701.1.S1_a_at
XI.7590.2.A1_x_at
XI.23306.1.S1_at

atf5
LOC397824
aldoc
LOC397951
cldn6

chromosomal passenger complex protein Dasra A
enhancer of split related epidermal protein-6
nucleoplasmin
homeobox protein
homeobox protein Xgbx-2
marginal coil Xmc
vitelline envelope 69/64 kDa glycoprotein
rho-GTPase activating protein
POU-domain protein
homeobox protein
histone H1-like maternal protein
XDCoH
cyclin B4
KH domain RNA-binding protein Sam68
VENT-2 transcription factor
repulsive guidance molecule A protein phosphatase 1D
magnesium-dependent, delta
isoform
activating transcription factor 5
dynein light chain 2
methylene tetrahydrofolate dehydrogenase
(NAD⫹dependent), methenyltetrahydrofolate
cyclohydrolase
activating transcription factor 5
homeobox protein Xgbx-2
aldolase C, fructose-bisphosphate
XDCoH
claudin 6

3.27
3.23
3.20
3.13

3.13
3.12
3.11
3.07
3.05

a
List of Xenopus laevis transcripts with expression up-regulated at least threefold in ﬁbroblast growth factor (FGF)-treated animal
cap explants from embryos injected with a Ctrl-speciﬁc morpholino (XctrlMO). Only annotated genes are listed.

Fig. 4. Reverse transcriptase-polymerase
chain reaction (RT-PCR) analysis of Xmc expression during early Xenopus development.
Xmc expression is zygotic, and coincides with
diminishment of maternal Xctr1 transcripts.

morphogenesis. Injection of an Xmcspeciﬁc morpholino (XmcMO) results
in a dose-dependent translational
block of a co-expressed Myc epitopetagged Xmc construct (Xmc-Myc) in
gastrula stage embryos (Fig. 5;
Frazzetto et al., 2002). This effect cannot be mimicked with either a control,
“scrambled” morpholino (CMO), or
with an Xmc-speciﬁc morpholino containing 5 base pair mismatches (XmcMM; Fig. 5). Injection of XmcMO has
been previously shown to generate

Fig. 5. XmcMO inhibits translation of 3⬘ Myctagged Xmc RNA (Xmc-Myc) containing the
XmcMO binding site. Xmc-Myc translation is
not inhibited by co-injection of a ﬁve base pair
mismatch Xmc morpholino (XmcMM), or a control scrambled morpholino (CMO). Western blot
of protein lysates from stage 10 Xenopus embryos, injected as listed, using anti-Myc and
anti-␤-tubulin antibodies, as shown (Sigma).

three phenotypic classes by the tadpole stage: embryos with a kinked
axis, embryos with a short axis, and
embryos with an open blastopore
(Class I, II, and III, after Frazzetto et
al., 2002). In our hands, dorsal marginal injection of 25 ng of XmcMO at
the four-cell stage results in 87% of

embryos with Class II defects, with
the remainder exhibiting Class III defects (N ⫽ 15). This dose of XmcMO
was used for subsequent Xmc loss-offunction studies.
Explant assays were used to test for
the potential requirement for Xmc in
Xctr1 knockdown-mediated morphogenesis. Elongation of FGF-treated
animal cap explants is enhanced following Xctr1 knockdown (Fig. 6A,B)
(Haremaki et al., 2007); this elongation is signiﬁcantly inhibited by coinjection of the Xmc-speciﬁc morpholino XmcMO (Fig. 6A,C). Inhibition of
Xctr1 knockdown-mediated elongation is not seen after injection of a 5
base pair mismatch Xmc morpholino
(XmcMM; Fig. 6D); moreover, the
block to inhibition by XmcMO can be
partially rescued by co-injection of
Xmc RNA lacking the XmcMO binding
site (Xmc), pointing to the speciﬁcity
of XmcMO for the Xmc transcript in
these assays (Fig. 6A,E). Xmc knockdown does not, however, inhibit elon-
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Fig. 6. Effects of Xmc loss-of-function on explant morphogenesis. A: Injection of morpholinos
against Xmc (XmcMO) inhibits Xctr1 knockdown-mediated morphogenesis in ﬁbroblast growth
factor (FGF) -treated animal cap explants at stage 22; this effect is rescued by co-expression of
Xmc RNA (Xmc) that lacks the XmcMO binding site. B–E: Quantiﬁcation of the requirement for Xmc
on explant morphogenesis. Error bars represent the standard error of the mean. y-axis ⫽ ratio of
cap length:cap width. B: Xctr1 knockdown increases elongation of FGF-treated animal caps. For
FGF, N ⫽ 17; for FGF/Xctr1MO, N ⫽ 19, with N ⫽ number of caps assayed. C: Xmc knockdown
inhibits Xctr1 knockdown-mediated elongation. For FGF/Xctr1MO, N ⫽ 19; for FGF/Xctr1MO/
XmcMO, N ⫽ 18. D: XmcMM does not inhibit Xctr1 knockdown-mediated elongation. For FGF/
Xctr1MO/XmcMO, N ⫽ 25; for FGF/Xctr1MO/XmcMM, N ⫽ 26. E: Suppression of Xctr1 knockdown-mediated elongation by XmcMO is rescued by co-expression of Xmc RNA lacking the
XmcMO binding site (Xmc). For FGF/Xctr1MO/XmcMO, N ⫽ 58; for FGF/Xctr1MO/XmcMO/Xmc,
N ⫽ 57. F: Xmc knockdown does not affect Activin-mediated elongation. For Activin, N ⫽ 8; for
Activin/XmcMO, N ⫽ 9. *P ⬍ 0.005; **P ⬍ 0.01. A total of 10 ng/ml bFGF, and 0.5 ng/ml Activin was
added, as shown. Also, 2 ng of Xmc RNA, 250 ng of Xctr1MO, 25 ng of XmcMO, and 25 ng of
XmcMM were injected, as shown.

gation of animal caps by Activin (Fig.
6F); thus, Xmc is required for FGFmediated, Xctr1-independent morphogenesis.

DISCUSSION
The presence or absence of the transmembrane protein Ctr1 dictates the

interpretation of FGF receptor activation as, respectively, either a pro-differentiation or a pro-morphogenesis
cue. Here, we demonstrate that Xmc is
a critical component of the signaling
cascade activated by FGF in the absence of Xctr1, as Xmc loss-of-function
inhibits Xctr1 knockdown-mediated
morphogenesis. This functional link is
buttressed by the temporal patterns of
expression of the two genes: the initiation of Xmc expression at gastrula
stages correlates with the initial decline in maternal Xctr1 expression levels, and also with the initiation of
FGF-mediated morphogenesis.
Xmc represents one of more than
two dozen genes whose expression is
induced following Xctr1 knockdown; it
was selected for further analysis because it was the only transcript that
was also suppressed following Xctr1
misexpression in ectodermal explants.
We have found, however, that Xctr1
misexpression, despite inhibiting explant and embryo elongation, does not
block Xmc expression in the presence
of FGF or Activin (this study, and Haremaki et al., 2007). This suggests that,
although Xmc is required for Xctr1-independent, FGF-mediated elongation,
Xmc suppression does not underlie
Xctr1-dependent inhibition of mesodermal elongation; early suppression of
Xmc may, however, play a role in the
inhibition of neural morphogenesis by
Xctr1. Other candidates from our
screens, perhaps including factors that
are not required for mediating Xctr1independent morphogenesis, may be involved in the suppression of premature
mesodermal morphogenesis downstream of Xctr1 (Haremaki et al., 2007);
we are beginning to test, in gain- and
loss-of-function assays, microarray targets whose expression is altered by
Xctr1 RNA, but not Xctr1 morpholino,
injection.

EXPERIMENTAL
PROCEDURES
Gene Chip Analysis
RNA from 80 animal cap explants,
cultured to stage 20, were used to generate hybridization probes for use on
Affymetrix GeneChip Xenopus laevis
Genome Arrays; hybridization was
performed with the help of the Mount
Sinai Microarray Shared Research Fa-
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cility (http://www.mssm.edu/research/
resources/microarray/). One nanogram
of Xctr1 or ␤-galactosidase RNA, 250 ng
of Xctr1MO or 250 ng of Xctr1MM morpholinos were injected, as described.
Microarray data were normalized by
RMA (Irizarry et al., 2003) and analyzed using the affylmGUI Bioconductor package (Wettenhall et al., 2006).
Normalized data were visualized by
MeV4.0 (Saeed et al., 2003).

Xmc Cloning and Mutant
Construction
An Image clone containing the Xenopus
marginal coil (Xmc) gene was obtained
from Open Biosystems (IMAGE ID:
6634521; accession no. BC072122). The
full coding sequence of Xmc was ampliﬁed by PCR and cloned into the EcoRI
and XhoI sites of pCS2⫹⫹. For XmcMyc, 16 base pairs of 5⬘-untranslated
region (UTR) and the coding sequence
of Xmc was subcloned upstream of six
Myc (EQKLISEEDLNEM) epitopes in
the CS2⫹MT vector; this construct contains the complete XmcMO binding
site. The Xmc construct used for morpholino rescue experiments lacks all 5⬘UTR and thus much of the XmcMO
binding site.

5⬘-AGCCTAAGCGAGTTGCTTTG;
Nucleoplasmin-D: 5⬘-TAGACTGGCAATCGGAACTG; DasraA-U: 5⬘-ACTACTGCTCTAACCAGGTC; DasraA-D:
5⬘-CTGTATCTCCTCTCAGTAGC;
ESR-6e-U: 5⬘- GGCACAGGGCAATACTGGT; ESR-6e-D: 5⬘-CCCCACTTGGCATTATGTTC; VENT-2-U: 5⬘-ACCCACTAATGGAAACCCTG; VENT-2-D:
5⬘- CACATGGCCCAATAT TAGCC;
Otx2-U: 5⬘-CGGGATGGATTTGTTGCA;
Otx2-D: 5⬘- TTGAACCAGACCTGGACT;
Xmc-U: 5⬘-CTGGTGTTACAGACCAAGGGG; Xmc-D: 5⬘-ACCTGTGCTTTTGCCACTC; Xctr1-U: 5⬘-GTGTGTCTGCTGGAAACTAAG; Xctr1-D: 5⬘TTCCCGCGAAATCTTCAG; ODC-U:
5⬘-AATGGATTTCAGAGACCA; ODC-D:
5⬘-CCAAGGCTAAAGTTGCAG.

Morpholinos
Morpholino oligos (Gene Tools) were
heated for 5 min at 65°C, then
quenched on ice, before injection at
the two- or four-cell stage. XmcMO: TGCAGC(CAT)TATGTATATGTAAAAA;
Xmc MM: TGgAGC(gAT)TATcTAaATcTAAAAA. Additional morpholino sequences are as described (Frazzetto et
al., 2002; Haremaki et al., 2007).
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